Home - Products - Others - Other Targets - Thalidomide-NH-PEG1-NH2 hydrochloride

Thalidomide-NH-PEG1-NH2 hydrochloride

CAS No. 2154342-56-8

Thalidomide-NH-PEG1-NH2 hydrochloride( 4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl )

Catalog No. M28662 CAS No. 2154342-56-8

Thalidomide-NH-PEG1-NH2 hydrochloride is a synthetic E3 ligase ligand-linker conjugate that incorporates the Thalidomide-based cereblon ligand and a linker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 124 Get Quote
10MG 178 Get Quote
25MG 308 Get Quote
50MG 447 Get Quote
100MG 664 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Thalidomide-NH-PEG1-NH2 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Thalidomide-NH-PEG1-NH2 hydrochloride is a synthetic E3 ligase ligand-linker conjugate that incorporates the Thalidomide-based cereblon ligand and a linker.
  • Description
    Thalidomide-NH-PEG1-NH2 hydrochloride is a synthetic E3 ligase ligand-linker conjugate that incorporates the Thalidomide-based cereblon ligand and a linker.
  • In Vitro
    PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vivo
    ——
  • Synonyms
    4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TGFβRI
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2154342-56-8
  • Formula Weight
    396.83
  • Molecular Formula
    C17H21ClN4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3NCCOCCN)=O.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Flavia Mercer Pernasetti, et al. Combinations of tgfb inhibitors and cdk inhibitors for the treatment of breast cancer. Patent WO2020058820A1.
molnova catalog
related products
  • 2-Adamantanone

    2-Adamantanone is a bioactive chemical.

  • PACMA 31

    PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.

  • Cinene

    Limonene is a monoterpene in citrus peel oil. A popular disinfectant and food preservative.